These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31749591)

  • 1. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by "tight control"?
    Gonczi L; Bessissow T; Lakatos PL
    World J Gastroenterol; 2019 Nov; 25(41):6172-6189. PubMed ID: 31749591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases.
    Dulai PS; Peyrin-Biroulet L; Danese S; Sands BE; Dignass A; Turner D; Mantzaris G; Schölmerich J; Mary JY; Reinisch W; Sandborn WJ
    Gastroenterology; 2019 Oct; 157(4):1032-1043.e1. PubMed ID: 31228441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing treatment paradigms for the management of inflammatory bowel disease.
    Im JP; Ye BD; Kim YS; Kim JS
    Korean J Intern Med; 2018 Jan; 33(1):28-35. PubMed ID: 29334728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Ansprenger C; Burri E
    Ther Umsch; 2019 Jan; 75(5):316-328. PubMed ID: 30700246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB
    Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2015 Jan; 50(1):74-80. PubMed ID: 25523558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease.
    Khanna R; Narula N; Feagan BG
    Inflamm Bowel Dis; 2018 Jul; 24(8):1619-1623. PubMed ID: 29846593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease.
    Fernandes SR; Bernardo S; Saraiva S; Gonçalves AR; Moura Santos P; Valente A; Correia LA; Cortez-Pinto H; Magro F
    United European Gastroenterol J; 2024 May; 12(4):451-458. PubMed ID: 38093503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease.
    Kwapisz L; Gregor J; Chande N; Yan B; Ponich T; Mosli M
    Scand J Gastroenterol; 2017 Aug; 52(8):846-850. PubMed ID: 28423962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
    Iborra M; Beltrán B; Nos P
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):641-56. PubMed ID: 27633593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions.
    Porter AC; Aubrecht J; Birch C; Braun J; Cuff C; Dasgupta S; Gale JD; Hinton R; Hoffmann SC; Honig G; Linggi B; Schito M; Casteele NV; Sauer JM
    Inflamm Bowel Dis; 2020 Sep; 26(10):1498-1508. PubMed ID: 32840322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases.
    Langhorst J; Boone J
    Drugs Today (Barc); 2012 Feb; 48(2):149-61. PubMed ID: 22384454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J
    Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic.
    Reinglas J; Restellini S; Gonczi L; Kurti Z; Verdon C; Nene S; Kohen R; Afif W; Bessissow T; Wild G; Seidman E; Bitton A; Lakatos PL
    Dig Liver Dis; 2019 Mar; 51(3):340-345. PubMed ID: 30591367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review.
    Colombel JF; D'haens G; Lee WJ; Petersson J; Panaccione R
    J Crohns Colitis; 2020 Feb; 14(2):254-266. PubMed ID: 31403666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimising monitoring in the management of Crohn's disease: a physician's perspective.
    Papay P; Ignjatovic A; Karmiris K; Amarante H; Milheller P; Feagan B; D'Haens G; Marteau P; Reinisch W; Sturm A; Steinwurz F; Egan L; Panés J; Louis E; Colombel JF; Panaccione R
    J Crohns Colitis; 2013 Sep; 7(8):653-69. PubMed ID: 23562672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.